Sintx Technologies (NASDAQ:SINT) and LENSAR (NASDAQ:LNSR) Head-To-Head Contrast

LENSAR (NASDAQ:LNSR – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of recent ratings and target prices for LENSAR and Sintx Technologies, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR 1 0 2 0 2.33
Sintx Technologies 1 0 3 0 2.50

LENSAR presently has a consensus price target of $11.00, suggesting a potential upside of 134.04%. Sintx Technologies has a consensus price target of $9.50, suggesting a potential upside of 516.88%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than LENSAR.

Institutional and Insider Ownership

40.1% of LENSAR shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 65.8% of LENSAR shares are owned by company insiders. Comparatively, 8.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares LENSAR and Sintx Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LENSAR 56.07% 1,254.25% 49.13%
Sintx Technologies -281.91% -309.86% -101.90%

Valuation and Earnings

This table compares LENSAR and Sintx Technologies”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LENSAR $58.44 million 0.99 -$34.28 million ($0.40) -11.75
Sintx Technologies $1.02 million 11.41 -$10.36 million ($1.69) -0.91

Sintx Technologies has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Summary

LENSAR beats Sintx Technologies on 7 of the 12 factors compared between the two stocks.

About LENSAR

(Get Free Report)

LENSAR, Inc. is a medical technology company focused on ophthalmic laser systems used in cataract surgery and other procedures involving the eye. The company develops and commercializes femtosecond laser technology designed to assist surgeons with key steps of cataract surgery, including corneal incisions, capsulotomy and lens fragmentation. Its product portfolio includes the LENSAR Laser System, which incorporates image-guidance and planning technologies intended to support precise, customized procedures.

About Sintx Technologies

(Get Free Report)

SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications. In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.